Skip to main content

Table 3 Association of CTC subgroups with general clinical characteristics of 64 patients. Data are presented as median (interquartile range)

From: Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer

Groups

TCTCs (/5ml)

ECTCs

EMCTCs

MCTCs

 SCC

14.00 (9.50,23.00)

1.00 (0.00,5.00)

6.00 (4.00,18.00)

3.00 (1.00,5.00)

 ADC

13.00 (10.00,20.00)

3.00 (0.00,6.50)

6.00 (3.50,10.00)

2.00 (1.00,4.50)

 SCA

9.00 (1.00,13.50)

2.00 (0.00,5.00)

2.00 (0.50,4.50)

1.00 (1.00,6.50)

χ 2

4.397

0.648

7.210

0.320

P

0.111

0.723

0.027*

0.852

TNM Stage

 

 I+II

8.00 (5.00,11.00)

2.00 (0.00,4.00)

4.00 (2.00,6.00)

1.00 (0.00,1.00)

 III + IV

15.50 (11.00,24.25)

2.00 (0.00,5.75)

6.50 (4.00,17.00)

3.00 (2.00,5.75)

Z

-4.394

-0.508

-2.806

-4.071

P

0.000*

0.611

0.005*

<0.001*

ECOG

    

 ≤ 1

11.00 (6.50,17.00)

3.00 (0.00,5.00)

6.00 (3.00,9.00)

1.00 (1.00,3.00)

 >1

14.50 (12.00,27.50)

2.00 (0.00,6.25)

7.00 (3.00,19.75)

4.00 (2.00,7.25)

Z

-2.291

-0.377

-1.255

-2.265

P

0.022*

0.706

0.209

0.024*

  1. Notes: *P < 0.05: statistical description: median (figures outside the parentheses) and interquartile range (figures in the parentheses)
  2. Abbreviations: CTCs, circulating tumor cells; ECTCs, epithelial circulating tumor cells; EMCTCs, epithelial–mesenchymal circulating tumor cells; MCTCs, mesenchymal circulating tumor cells; TCTCs, total CTCs. SCC, squamous cell carcinoma; ADC, adenocarcinoma; SCA, small cell cancer. (SCC)